The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Menopausal Disorder Treatment Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The menopausal disorder treatment market size has demonstrated significant growth in recent years. It is anticipated to expand from $11.47 billion in 2025 to $12.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, this growth has been driven by factors such as an increasing aging female population, the widespread use of hormone replacement therapy, a rise in the diagnosis of menopausal symptoms, the expansion of gynecology care services, and enhanced healthcare access for women.
The menopausal disorder treatment market size is projected for significant expansion in the upcoming years. It is forecasted to reach $16.26 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This growth over the forecast period is attributed to the rising demand for safer menopause treatments, an increasing focus on individualized therapy plans, growing awareness of long-term HRT risks, the expansion of digital women’s health platforms, and the increasing adoption of preventive women’s healthcare. Major trends anticipated in this period include a growing preference for non-hormonal menopause therapies, the increasing adoption of personalized hormone replacement therapy, a wider utilization of lifestyle and behavioral interventions, the expansion of herbal and natural menopause treatments, and greater awareness of menopause symptom management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Menopausal Disorder Treatment Market?
The increasing need for hormone replacement therapies (HRT) is anticipated to fuel expansion in the menopausal disorder treatment market moving ahead. HRT is a medical approach involving the supplementation or replacement of hormones to ease symptoms linked to menopause or hormonal imbalances. The rise in these therapies stems from heightened awareness and a desire for effective management of menopausal indications and hormonal discrepancies. HRT addresses menopausal disorders by directly restoring estrogen and progesterone levels, which aids in re-establishing hormonal equilibrium and mitigating troublesome symptoms like hot flashes, night sweats, and mood fluctuations, thereby enhancing overall quality of life. For example, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based entity offering various support services, reported a 22% surge in prescribed HRT items, reaching 13 million. Concurrently, the number of identified patients grew by 12%, from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the escalating demand for hormone replacement therapies is a significant driver for the growth within the menopausal disorder treatment market.
What Major Segment Divisions Exist Within The Menopausal Disorder Treatment Market?
The menopausal disorder treatment market covered in this report is segmented –
1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications
2) By Stages: Menopause, Postmenopause, Perimenopause
3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets
2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements
3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed
4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices
How Are Trends Shaping The Direction Of The Menopausal Disorder Treatment Market?
Leading companies in the menopausal disorder treatment market are innovating nonhormonal neurokinin 3 (NK3) receptor antagonist medications to effectively address vasomotor symptoms, bypassing the need for hormone therapy. These pioneering nonhormonal neurokinin 3 (NK3) receptor antagonist therapies function by blocking NK3 receptors to alleviate menopausal symptoms without relying on hormones. An example occurred in December 2023 when Astellas Pharma Inc., a Japan-based pharmaceutical firm, gained European Commission approval for Veozah (fezolinetant). This non-hormonal NK3 receptor antagonist is intended for managing moderate to severe vasomotor symptoms (VMS), such as hot flashes and night sweats, in menopausal women. Its action involves targeting neurons in the brain’s temperature control center, which helps diminish the frequency and intensity of these symptoms.
Which Companies Are Leading Innovation In The Menopausal Disorder Treatment Market?
Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.
Read the full menopausal disorder treatment market report here:
https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report
What Are The Leading Geographic Regions In The Menopausal Disorder Treatment Market?
North America was the largest region in the menopausal disorder treatment market in 2025. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Menopausal Disorder Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp
Browse Through More Reports Similar to the Global Menopausal Disorder Treatment Market 2026, By The Business Research Company
Menopausal Hot Flashes Market Report 2026
https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report
Menopause Market Report 2026
https://www.thebusinessresearchcompany.com/report/menopause-global-market-report
Hormone Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model